Longevity Venture Partners

Longevity Venture Partners reads the demographic data the way an actuary would. The aging of populations across developed markets is not a marketing trend but a structural reality, and the fund is built around the proposition that the companies serving this transition are still being founded.

The thesis is to back early-stage companies addressing aging populations through silver-tech, predictive diagnostics, remote patient monitoring, preventative care, and the broader category of digital health and wellness products oriented toward older adults and the people who care for them. AI is treated as a foundational input rather than a feature. The fund expects the next generation of useful products to apply machine learning to the messy, longitudinal, multi-condition reality of older patients in ways that earlier digital health tooling never quite managed. The portfolio is being built around that conviction, with attention to home-based care, fall prevention, cognitive health, chronic disease management, and adjacent wellness categories.

Checks fall in the one to five million dollar range, written at Seed and Series A. The fund will lead at Seed when the founder and the thesis line up cleanly, and will participate selectively at Series A. Geography centers on Israeli founders, almost always selling into the US and European markets where the demographic curve is steepest and the willingness to pay is meaningful. The fund is comfortable with companies selling into payers, Medicare Advantage plans, employers, providers, and direct-to-consumer channels in segments where older adults have meaningful purchasing power and decision-making autonomy.

The team operates with the focus of a specialist fund, which means founders skip the work of explaining why aging matters as a market and can move directly to the substance of their product. The fund’s networks across senior care providers, Medicare-focused payers, and aging-services organizations give it real leverage in the parts of the go-to-market that founders chronically underestimate.

In practice, Longevity Venture Partners helps where aging-focused companies tend to stumble. That includes designing products that older adults will actually use rather than versions of consumer apps with larger fonts, navigating the procurement and reimbursement quirks of Medicare Advantage and senior-living operators, and building clinical evidence that holds up under payer scrutiny. The fund is direct that pure youth-focused consumer wellness or therapeutics plays without a longevity angle are not the right fit. For founders building digital health and wellness companies aimed at older adults, the fund is one of the few specialists in Israel with the conviction, the network, and the check size to lead at the early stage. The diligence is grounded, the engagement is hands-on, and the operating support reflects a real understanding of why most companies serving older adults underperform their slide decks.